表面抗原の正確な組み合わせで細胞をターゲットに設計されたタンパク質ロジック
Marc J Lajoie1,2, Scott E Boyken3,2, Alexander I Salter4,5
1Institute for Protein Design, University of Washington, Seattle, WA, USA. mlajoie@lyell.com dabaker@uw.edu.
まとめ
研究者は,精密な細胞標的化のためのコロカライゼーション依存タンパク質スイッチ (Co-LOCKR) を開発した. これらのエンジニアリングされたタンパク質はブール論理演算を行い,高度な細胞計算と標的治療のための AND,OR,および NOT機能を可能にします.
科学分野:
- 生物化学
- 合成生物学
- 免疫学
背景:
- 哺乳類の細胞の識別は,ユニークな表面マーカーの欠如のために複雑です.
- 特定の細胞集団をターゲットにするには,単一のマーカー認識を超えた方法が必要です.
研究 の 目的:
- ブール論理演算 (AND,OR,NOT) を実行できる新しいタンパク質ベースのスイッチを設計する.
- 複雑な生物システム内の単細胞解像度で正確な,転写独立の細胞反応を可能にします.
- これらのスイッチが標的がん治療のためのT細胞特異性をリダイレクトする際の応用を実証する.
主な方法:
- コロカライゼーション依存タンパク質スイッチ (Co-LOCKR) の設計と工学.
- AND,OR,そしてNOTのロジックゲートを実行するCo-LOCKRシステムの実装.
- 特定の表面抗原の組み合わせを持つ腫瘍細胞に対するT細胞再誘導のためのCo-LOCKRの適用.
主要な成果:
- Co-LOCKRスイッチは AND,OR,そして NOTのブール式論理操作を成功裏に実行した.
- エンジニアリングされたANDゲートは,単一の抗原細胞を避けながら,二重抗原を発現する腫瘍細胞のT細胞標的化を可能にしました.
- 3つの入力スイッチは,追加の抗原の存在に基づいて細胞標的を精製するために, NOT または OR ロジックを統合した.
結論:
- 細胞表面で計算論理を実行できる
- Co-LOCKR技術は,精密な細胞標的と治療用途のための多用途のプラットフォームを提供します.
- このアプローチは,複数の結合イベントを単一の機能的な出力に洗練された統合を可能にします.
関連する概念動画
Diversity of Antigen Receptors
1.2K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.2K
Special Features of Adaptive Immunity
2.7K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.7K
Antigens Involved in Adaptive Immunity
1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
T Cell Activation and Clonal Selection
14.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.3K
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K


